Why the study?
Preemptive kidney transplant is associated with reduced cardiovascular risk, but the cardiovascular benefits of kidney transplant with versus without previous chronic hemodialysis required further investigation.
Does preemptive kidney transplant compared to transplant after chronic hemodialysis improve cardiac morphological and functional parameters in patients with end-stage renal disease?
Does preemptive kidney transplant compared to transplant after chronic hemodialysis improve cardiac morphological and functional parameters in patients with end-stage renal disease?
Answers are grounded in this paper and cite their sources.
Preemptive kidney transplant is associated with less adverse cardiac structural and functional remodeling compared to transplant following chronic hemodialysis, supporting its use to mitigate cardiovascular risk in end-stage renal disease.
Patients with end-stage renal disease have higher cardiovascular morbidity and mortality compared with the general population. Preemptive kidney transplant (KTx) has been shown to be associated with improved survival, better quality of life, lower healthcare burden, and reduced cardiovascular risk. In this case-control study, we investigated the cardiovascular benefits of two approaches to KTx: with and without previous chronic hemodialysis. We enrolled 21 patients who underwent preemptive KTx and 21 matched controls who received chronic hemodialysis before KTx. Cardiac morphological and functional parameters were assessed by echocardiography. Overall, patients undergoing preemptive KTx showed less extensive cardiac damage compared with controls, as evidenced by higher global longitudinal strain, peak atrial and contractile strain, and early diastolic mitral annular velocity as well as a lower left ventricular mass, left atrial volume index, and the ratio of mitral inflow early diastolic velocity to the mitral annular early diastolic velocity. In the multivariable analysis, the presence of chronic hemodialysis prior to KTx was an independent determinant of post-transplant cardiac functional and structural remodeling. These findings may have important clinical implications, supporting the use of preemptive KTx as a preferred treatment strategy in patients with end-stage renal disease.
No takes yet. Share an insight, caveat, or question.
Obremska et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: